|Last Price$135.06||Day Change (%)-1.99%|
|Open Price$137.00||Day Change ($)-2.74|
|Day Range134.15–137.05||52-Week Range99.41–142.75|
As of Fri 03/07/2014 04:00 PM EST | USD
Bayer HealthCare and Regeneron Announce Regulatory Submission of EYLEA® (aflibercept) Injection for the Treatment of Diabetic Macular Edema in Japan
More than a dozen analyst-approved foreign large-cap funds own these names.
GreenLight Biosciences Announces New Partnership with Bayer CropScience
Regeneron Announces FDA Acceptance of EYLEA® (aflibercept) Injection Supplemental Biologics License Application for the Treatment of Macular Edema Following Branch Retinal Vein Occlusion
Research and Markets: Latest News on China's Fungicides Industry
The diversified health-care firm remains remarkably profitable in tough industries.
Regeneron Reports Fourth Quarter and Full Year 2013 Financial and Operating Results
Research and Markets: Glucose Monitoring Device Market to 2019 - Technology Adoption and Increasing Health Awareness Serve as Distinct Regional Growth Drivers
Research and Markets: Raynauds Disease - Pipeline Review, H2 2013 Research Report
Research and Markets: Concise Analysis of the International Styrenics Market: Polystyrene, Acrylonitrile Butadiene Styrene, SBR, UPR - Forecasts to 2018